Hepatic and Intestinal Schistosomiasis: Review

Journal of Advanced Research

Volumn 4, Issue 5, 2013, Pages 445-452

  Elbaz, Tamer ^a   Esmat, Gamal ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Hepatic schistosomiasis; Intestinal schistosomiasis; Portal hypertension; Praziquantel

Indexed keywords

EID: 84881659841     PISSN: 20901232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jare.2012.12.001     Document Type: Review

References (76)

1. Badr M. Detection of bladder cancer. Bladder cancer 1981, 1. Al-Ahram Press. El-Bolkany, Chu (Eds.).
2. Burke M.L., Jones M.K., Gobert G.N., Li Y.S., Ellis M.K., McManus D.P. Immunopathogenesis of human schistosomiasis. Parasite Immunol 2009, 31:163-176.
3. Sarvel A.K., Oliveira A.A., Silva A.R., Lima A.C., Katz N. Evaluation of a 25-year-program for the control of schistosomiasis mansoni in an endemic area in Brazil. PLoS Negl Trop Dis 2011, 5:e990.
4. Hagan P., Gryseels B. Schistosomiasis research and the European community. Trop Geogr Med 1994, 46:259-268.
5. Hotez P.J., Savioli L., Fenwick A. Neglected tropical diseases of the middle East and North Africa: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis 2012, 6(2):e1475.
6. Abdel-Wahab M.F., Strickland G.T., El-Sahly A., El-Kady N., Zakaria S., Ahmed L. Changing pattern of schistosomiasis in Egypt, 1935-1979. Lancet 1979, 2:242-244.
7. Abdel-Wahab M.F., Yosery A., Narooz S., Esmat G., el Hak S., Nasif S., et al. Is Schistosoma mansoni replacing Schistosoma haematobium in the Fayoum?. Am J Trop Med Hyg 1993, 49:697-700.
8. Cline B.L., Richards F.O., El Alamy M.A., El Hak S., Ruiz-Tiben E., Hughes J.M., et al. 1983 Nile Delta schistosomiasis survey: 48years after Scott. Am J Trop Med Hyg 1989, 41:56-62.
9. Michelson M.K., Aziz F.A., Gamil F.M., Wahid A.A., Richards F.O., Juranek D.D., et al. Recent trends in the prevalence and distribution of schistosomiasis in the Nile delta region. Am J Trop Med Hyg 1993, 49:76-87.
10. El-Khoby T., Galal N., Fenwick A., Barakat R., El-Hawey A., Nooman Z., et al. The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates. Am J Trop Med Hyg 2000, 62:88-99.
11. Lambertucci J.R., Cota G.F., Pinto-Silva R.A., Serufo J.C., Gerspacher-Lara R., Costa Drummond S., et al. Hepatosplenic schistosomiasis in field-based studies: a combined clinical and sonographic definition. Mem Inst Oswaldo Cruz 2001, 96:147-150.
12. Van der Kleij D., Latz E., Brouwers J.F., Kruize Y.C., Schmitz M., Kurt-Jones E.A., et al. A novel host parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 2002, 277:48122-48129.
13. Wynn T.A., Thompson R.W., Cheever A.W., Mentink-Kane M.M. Immunopathogenesis of schistosomiasis. Immunol Rev 2004, 201:156-167.
14. Wilson M.S., Mentink-Kane M.M., Pesce J.T., Ramalingam T.R., Thompson R., Wynn T.A. Immunopathology of schistosomiasis. Immunol Cell Biol 2007, 85(2):148-154.
15. Morais C.N., Souza J.R., Melo W.G., Aroucha M.L., Miranda P., Domingues A.L., et al. Cytokine profile associated with chronic and acute human schistosomiasis mansoni. Mem Inst Oswaldo Cruz 2008, 103:561-568.
16. Gryseels B., Polman K., Clerinx J., Kestens L. Human schistosomiasis. Lancet 2006, 368:1106-1118.
17. Stadecker M.J., Asahi H., Finger E., Hernandez H.J., Rutitzky L.I., Sun J. The immunobiology of Th1 polarization in high pathology schistosomiasis. Immunol Rev 2004, 201:168-179.
18. Andrade Z.A., Santana T.S. Angiogenesis and schistosomiasis. Mem Inst Oswaldo Cruz 2010, 105:436-439.
19. Symmers W.S.C. Note on a new form of liver cirrhosis due to the presence of ova of Bilharzia haematobilium. J Pathol Bacteriol 1904, 9:237-239.
20. Andrade Z.A., Baptista A.P., Santana T.S. Remodeling of hepatic vascular changes after specific chemotherapy of schistosomal periportal fibrosis. Mem Inst Oswaldo Cruz 2006, 101:267-272.
21. Andrade Z.A. Extracellular matrix degradation in parasitic diseases. Br J Med Biol Res 1994, 27:2273-2281.
22. Frank C., Mohamed M.K., Strickland G.T., Lavanchy D., Arthur R.R., Magder L.S., et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000, 355:887-891.
23. Lundy S.K., Lerman S.P., Boros D.L. Soluble egg antigen stimulated T-helper lymphocyte apoptosis and evidence for cell death mediated by FasL+T and B cells during murine Schistosoma mansoni infection. Infect Immun 2001, 69:271-280.
24. Farid A., Al-Sherbiny M., Osman A., Mohamed N., Saad A., Shata M.T., et al. Schistosoma infection inhibits cellular immune responses to core HCV peptides. Parasite Immunol 2005, 27:89-96.
25. Kamal S.M., Turner B., He Q., Rasenack J., Bianchi L., Al Tawil A., et al. Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology 2006, 43:771-779.
26. Andrade Z.A. Schistosomal hepatopathy. Mem Inst Oswaldo Cruz 2004, 99:51-57.
27. Ismail M.M., Attia M.M., El-Badawy A.A., Farghaly A.M., Husein M.H., Metwally A. Treatment of schistosomiasis with Praziquantel among school children. J Egypt Soc Parasitol 1994, 24:487-494.
28. El-Garem A.A. Schistosomiasis. Digestion 1998, 59:589-605.
29. Ata A.A., Raziky S.H., El-Hawey A.M., Rafla H. A clinicopathological study of schistosomal colonic polyposis and their pathogenesis. J Egypt Med Assoc 1970, 53:767-772.
30. Strickland G.T. Leading article: tropical infections of the gastrointestinal tract and liver series. Gastrointestinal manifestations of schistosomiasis. Gut 1994, 35:1334-1337.
31. Mostafa I. Schistosomal colonic polyposis. Gastrointest Endosc 1997, 46:584-587.
32. Cao J., Liu W.J., Xu X.Y., Zou X.P. Endoscopic findings and clinicopathologic characteristics of colonic schistosomiasis: a report of 46 cases. World J Gastroenterol 2010, 16:723-727.
33. Thakeb F., El-Kalouby A.H., Ibrahim I.M., Hunter S., Zakaria S. Colonoscopic polypectomy in management of schistosomal colonic polyposis. Egypt J Bilh 1980, 7:49-56.
34. Mostafa IM, Zakaria S, Khalil A, El-Kaluoby A. The effect of medical treatment and endoscopic polypectomy on clinicopathological, immunological and endoscopic aspects of schistosomal colonic polyposis in Egypt. In: Proceedings of the world congresses of gastroenterology 1990; Sydney, Australia; 1260.
35. El Malatatwy A., El Habashy A., Lechine N., Dixon H., Davis A., Mott K.E. Selective population chemotherapy among school children in Beheira Governate: the UNICEF/Arab Republic of Egypt/WHO Schistosomiasis Contrl Project. Bull World Health Organization 1992, 70:47-56.
36. Abaza H., Asser L., Mostafa S., El Mallah S. Management of schistosomal colonic polyposis. J Egypt Med Assoc 1986, 69:101-110.
37. Dimmette R.M., Sproat H.F. Recto-sigmoid polyps in schistosomiasis. General clinical and pathological considerations. Am J Trop Med Hyg 1955, 4:1057-1067.
38. Farid Z., Bassily S., Lehman J.S., Kent D.C., Haxton J., Patwardhan V.N., et al. Iron loss and reabsorption in Ancylostoma duodenale infection and bilharzial colonic polyposis. Trans R Soc Trop Med Hyg 1970, 64:881-884.
39. Nebel O.T., El Masry N.A., Castell D.O., Farid Z., Fornes M.F., Sparks H.A. Schistosomal disease of the colon. A reversible form of polyposis. Gastroenterology 1974, 67:939-949.
40. Barsoum H. Cancer in Egypt: its incidence and clinical forms. Acta Uni Intern ConCan 1953, 9:241-250.
41. El-Rooby A. The gastroenterology of schistosomiasis in complied review of bilharziasis. The national information and documentation center (NIDOC). Cairo 1991, 137-143.
42. Mohamed A.R., Al Karawi M., Yasawy M.I. Schistosomal colonic disease. Gut 1990, 31:439-442.
43. Xu Z., Su D.L. Schistosoma Japonicum and colorectal cancer: an epidemiological study in the People's Republic of China. Int J Cancer 1984, 34:315-318.
44. Salim H.O., Hamid H.K., Mekki S.O., Suleiman S.H., Ibrahim S.Z. Colorectal carcinoma associated with schistosomiasis: a possible causal relationship. World J Surg Oncol 2010, 8:68.
45. López de Cenarruzabeitia I., Landolfi S., Armengol Carrasco M. Intestinal schistosomiasis as unusual aetiology for acute appendicitis, nowadays a rising disease in Western countries. Case Rep Infect Dis 2012, 2012:896820.
46. Leder K, Weller PF. Diagnosis and treatment of schistosomiasis. Version 14.3UpToDate 2005. .
47. Carneiro T.R., Pinheiro M.C., Oliveira S.M., Hanemann A.L., Queiroz J.A., Bezerra F.S. Increased detection of schistosomiasis with Kato-Katz and SWAP-IgG-ELISA in a Northeastern Brazil low-intensity transmission area. Rev Soc Bras Med Trop 2012, 45(4):510-513.
48. Elliott D.E. Schistosomiasis. Pathophysiology, diagnosis, and treatment. Gastroenterol Clin North Am 1996, 25:599-625.
49. Wichmann D., Panning M., Quack T., Kramme S., Burchard G.D., Grevelding C., et al. Diagnosing schistosomiasis by detection of cell-free parasite DNA in human plasma. PLoS Negl Trop Dis 2009, 3:e422.
50. Deelder A.M., Qian Z.L., Kremsner P.G., Acosta L., Rabello A.L., Enyong P., et al. Quantitative diagnosis of Schistosoma infections by measurement of circulating antigens in serum and urine. Trop GeogrMed 1994, 46:233-238.
51. Navaratnam A.M., Mutumba-Nakalembe M.J., Stothard J.R., Kabatereine N.B., Fenwick A., Sousa-Figueiredo J.C. Notes on the use of urine-CCA dipsticks for detection of intestinal schistosomiasis in preschool children. Trans R Soc Trop Med Hyg 2012, 106(10):619-622.
52. Hussein H.M., El-Tonsy M.M., Tawfik R.A., Ahmed S.A. Experimental study for early diagnosis of prepatent schistosomiasis mansoni by detection of free circulating DNA in serum. Parasitol Res 2012, 111(1):475-478.
53. Pontes L.A., Oliveira M.C., Katz N., Dias-Neto E., Rabello A. Comparison of a polymerase chain reaction and the Kato-Katz technique for diagnosing infection with Schistosoma mansoni. Am J Trop Med Hyg 2003, 68:652-656.
54. Shiff C. The importance of definitive diagnosis in chronic schistosomiasis, with reference to Schistosoma haematobium. J Parasitol Res 2012, 2012:761269.
55. Gomes L.I., Marques L.H., Enk M.J., Coelho P.M., Rabello A. Further evaluation of an updated PCR assay for the detection of Schistosoma mansoni DNA in human stool samples. Mem Inst Oswaldo Cruz 2009, 104:1194-1196.
56. Abdel-Wahab M.F., Esmat G., Farrag A., El-Boraey Y.A., Strickland G.T. Grading of hepatic schistosomiasis by the use of ultrasonography. Am J Trop Med Hyg 1992, 46:403-408.
57. Pinto-Silva R.A., Queiroz L.C., Azeredo L.M., Silva L.C., Lambertucci J.R. Ultrasound in schistosomiasis mansoni. Mem Inst Oswaldo Cruz 2010, 105:479-484.
58. Wilson S., Vennervald B.J., Dunne D.W. Chronic hepatosplenomegally in African school children: a common but neglected morbidity associated with schistosomiasis and malaria. PLoS Negl Trop Dis 2011, 5(8):e1149.
59. Prichard R.K., Basáñez M.G., Boatin B.A., McCarthy J.S., García H.H., Yang G.J., et al. A research agenda for Helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis 2012, 6(4):e1549.
60. Cioli D., Basso A., Valle C., Pica-Mattoccia L. Decades down the line: the viability of praziquantel for future schistosomiasis treatment. Expert Rev Anti Infect Ther 2012, 10(8):835-837.
61. Navaratnam A.M., Sousa-Figueiredo J.C., Stothard J.R., Kabatereine N.B., Fenwick A., Mutumba-Nakalembe M.J. Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety. Trans R Soc Trop Med Hyg 2012, 106(7):400-407.
62. Keiser J., Utzinger J. Antimalarials in the treatment of schistosomiasis. Curr Pharm Des 2012, 18(24):3531-3538.
63. Pavlin BI, Kozarsky P, Cetron MS. Acute pulmonary schistosomiasis in travelers: case report and review of the literature. Travel Med Infect Dis 2012 S pii: S1477-8939(12)00084-1. doi: http://dx.doi.org/10.1016/j.tmaid.2012.06.001. doi:10.1016/j.tmaid.2012.06.001.
64. del Villar L.P., Burguillo F.J., López-Abán J., Muro A. Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis. PLoS One 2012, 7(9):e45867.
65. Deng W.C., Li J.X., Pan K., Kong G.Q., He Y.K., Li Y.S. Recommendation of a new clinical classification of advanced schistosomiasis. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2012, 24(2):235-236.
66. Mahmoud A.A.F.M. Schistosomiasis. Tropical medicine: science and practice 2001, 1-510. Imperial College Press, London. G. Pasvol, S. Hoffman (Eds.).
67. De Franchis R. Evolving consensus in portal hypertension report of the baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005, 43:167-176.
68. Hussein A.M., Medany S., Abou El-Magd A.M., Sherif S.M., Williams C.B. Multiple endoscopic polypectomies for schistosomal polyposis of the colon. Lancet 1983, 1:673-674.
69. Williams C.B., Hunt R.H., Loose H., Ridel R.H., Skai Y., Swarbrick E.T. Colonoscopy in the management of colon polyps. Br J Surg 1974, 61:673-682.
70. Todd C.W., Colley D.G. Practical and ethical issues in the development of a vaccine against schistosomiasis mansoni. Am J Trop Med Hyg 2002, 66:348-358.
71. McManus D.P., Loukas A. Current status of vaccines for schistosomiasis. Clin Microbiol Rev 2008, 21:225-242.
72. Wilson R.A., Coulson P.S. Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour. Trends Parasitol 2009, 25:423-431.
73. Tran M.H., Freitas T.C., Cooper L., Gaze S., Gatton M.L., Jones M.K., et al. Suppression of mRNAs encoding tegument tetraspanins from Schistosoma mansoni results in impaired tegument turnover. PLoS Pathog 2010, 6:e1000840.
74. Pearson M.S., Pickering D.A., McSorley H.J., Bethony J.M., Tribolet L., Dougall A.M., et al. Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2. PLoS Negl Trop Dis 2012, 6(3):e1564.
75. Ramos C.R., Spisni A., Oyama S., Sforça M.L., Ramos H.R., Vilar M.M., et al. Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate. Biochim Biophys Acta 2009, 1794:655-662.
76. Da'dara A.A., Li Y.S., Xiong T., Zhou J., Williams G.M., McManus D.P., et al. DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine 2008, 26:3617-3625.